Sign in
Taking people in United StatesPhase 2

buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest

Key facts

Who runs it
University of California, San Francisco
Where
San Francisco, United StatesSee the site
Trial code
Status
Recruiting
Phase
Phase 2
People taking part
30 people, planned
Started
7 Aug 2023
Expected to end
30 Apr 2028
Type of study
Interventional, 2 groups
Treatments tested
  • Burst Suppression EEG Target Intravenous Anesthesia
  • Seizure Suppression EEG Target Intravenous Anesthesia
Record updated
29 July 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Age ≥18 years old
  • Non-traumatic, out-of-hospital cardiac arrest
  • Comatose on admission - defined as not following commands
  • Return of spontaneous circulation (ROSC) within less than 45 minutes
  • Admission to the intensive care unit
  • Diagnosis of post-cardiac arrest refractory status epilepticus confirmed with continuous; EEG monitoring within 7 days from ROSC

Who cannot take part

  • Acute cerebral hemorrhage or infarction
  • Pregnancy
  • Prisoners

This trial is currently available in United States.

  • Zuckerberg San Francisco General HospitalSan Francisco, United StatesContact: Edilberto Amorim, MDTaking people

About the trial

What the trial wants to find out

RESTORE is a randomized clinical trial investigating the safety and feasibility of using EEG treatment targets (burst suppression vs. seizure suppression) for post-cardiac arrest refractory status epilepticus treatment.

The 2 groups in the trial

  • Burst Suppression EEG TargetOther group

    Anesthetic will be titrated to achieve burst suppression on continuous EEG (50-99% attenuation/suppression) for 24 hours.

    Treatment: Burst Suppression EEG Target Intravenous Anesthesia

  • Seizure Suppression EEG TargetOther group

    Anesthetic will be titrated to achieve seizure suppression on continuous EEG for 24 hours.

    Treatment: Seizure Suppression EEG Target Intravenous Anesthesia

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest (RESTORE)
Record updated
29 July 2026